Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro
Open Access
- 23 January 2017
- journal article
- research article
- Published by Springer Nature in BMC Cell Biology
- Vol. 18 (1) , 1-10
Abstract
Sprouting angiogenesis requires vascular endothelial proliferation, migration and morphogenesis. The process is regulated by soluble factors, principally vascular endothelial growth factor (VEGF), and via bidirectional signaling through the Jagged/Notch system, leading to assignment of tip cell and stalk cell identity. The cytokine transforming growth factor beta (TGF-β) can either stimulate or inhibit angiogenesis via its differential surface receptor signaling. Here we evaluate changes in expression of angiogenic signaling receptors when bovine aortic endothelial cells were exposed to TGF-β1 under low serum conditions. TGF-β1 induced a dose dependent inhibition of tip cell assignment and subsequent angiogenesis on Matrigel, maximal at 5.0 ng/ml. This occurred via ALK5-dependent pathways and was accompanied by significant upregulation of the TGF-β co-receptor endoglin, and SMAD2 phosphorylation, but no alteration in Smad1/5 activation. TGF-β1 also induced ALK5-dependent downregulation of Notch1 but not of its ligand delta-like ligand 4. Cell associated VEGFR2 (but not VEGFR1) was significantly downregulated and accompanied by reciprocal upregulation of VEGFR2 in conditioned medium. Quantitative polymerase chain reaction analysis revealed that this soluble VEGFR2 was not generated by a selective shift in mRNA isoform transcription. This VEGFR2 in conditioned medium was full-length protein and was associated with increased soluble HSP-90, consistent with a possible shedding of microvesicles/exosomes. Taken together, our results suggest that endothelial cells exposed to TGF-β1 lose both tip and stalk cell identity, possibly mediated by loss of VEGFR2 signaling. The role of these events in physiological and pathological angiogenesis requires further investigation.Keywords
Funding Information
- Canadian Cancer Society Research Institute (2012-701069)
- Canadian Foundation for Innovation (26472)
This publication has 45 references indexed in Scilit:
- Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signalingOncogene, 2013
- A Proteome Comparison Between Physiological Angiogenesis and Angiogenesis in GlioblastomaMolecular & Cellular Proteomics, 2012
- TGF-β1 Induces Endothelial Cell Apoptosis by Shifting VEGF Activation of p38MAPK from the Prosurvival p38β to Proapoptotic p38αMolecular Cancer Research, 2012
- TGFβ signalling: a complex web in cancer progressionNature Reviews Cancer, 2010
- The regulation of TGFβ signal transductionDevelopment, 2009
- Role of transforming growth factor-β superfamily signaling pathways in human diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-β in Vascular MorphogenesisCirculation Research, 2008
- Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III ReceptorJournal of Biological Chemistry, 2008
- VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosisProceedings of the National Academy of Sciences, 2006
- Biphasic Effect of Transforming Growth Factor-β1 on in Vitro AngiogenesisExperimental Cell Research, 1993